Thin-EBUS in Ex-vivo Human Lungs

Not Applicable

Completed

• Conditions: Lung Cancer
• Interventions: Device: Thin Convex Probe Endobronchial Ultrasound (TCP-EBUS)

• Registration Number: NCT03349307
• Lead Sponsor: University Health Network, Toronto

Brief Summary

This study will determine the feasibility of the novel thin convex probe endobronchial ultrasound (TCP-EBUS) in human resected lobes. The primary end point is to clarify the feasibility of using the thin convex probe EBUS scope to visualize lung tumors from an intra-bronchial view. The secondary objective is to evaluate the insertion ability, operability, endoscopic image and ultrasound image compared to that of the convex probe EBUS.

Detailed Description

Not available

Study Timeline

• Study Start: 2017-07-12
• Study First Submitted: 2017-11-13
• Study First Submitted QC: 2017-11-16
• Study First Posted: 2017-11-21
• Status Verified: 2018-05
• Primary Completion: 2018-05-01
• Study Completion: 2018-05-01
• Last Update Submitted: 2018-05-07
• Last Update Posted: 2018-05-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• Any patients scheduled for lobectomy or anatomical segmental resection for malignant lung tumors.
• 18 years of age or older

Exclusion Criteria

• Any patients with inability to give informed consent.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
No Intervention	Thin Convex Probe Endobronchial Ultrasound (TCP-EBUS)	-

Primary Outcome Measures

Name	Time	Method
To clarify the feasibility of using the thin convex probe EBUS scope to visualize lung tumors from an intra bronchial view.	Within an hour of resection.	The TCP-EBUS bronchoscope will be inserted through the endotracheal tube for visualization of lobar, segmental and sub segmental bronchi.

Trial Locations

Locations (1)

Toronto General Hospital; 🇨🇦 Toronto, Ontario, Canada